Comments
Loading...
Cytokinetics (CYTK) Forecast
NewsEarningsCytokinetics (CYTK) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCytokinetics (NASDAQ:CYTK) Stock Quotes, Forecast and News Summary
Cytokinetics Stock (NASDAQ: CYTK) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cytokinetics (CYTK) stock?
You can purchase shares of Cytokinetics (NASDAQ:CYTK) through any online brokerage.
Who are Cytokinetics (CYTK) competitors?
Other companies in Cytokinetics’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE) and Exact Sciences (NASDAQ:EXAS).
What is the forecast, or price target, for Cytokinetics (CYTK) stock?
Cytokinetics has a consensus price target of $80.06.
What is the current price for Cytokinetics (CYTK)?
The stock price for Cytokinetics (NASDAQ: CYTK) is $47.83 last updated November 22, 2024 at 9:30 AM EST.
Does Cytokinetics (CYTK) pay a dividend?
There are no upcoming dividends for Cytokinetics.
When is Cytokinetics (NASDAQ:CYTK) reporting earnings?
Cytokinetics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Cytokinetics (CYTK) going to split?
There is no upcoming split for Cytokinetics.
What sector and industry does Cytokinetics (CYTK) operate in?
Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.